APA (7th ed.) Citation

I, S., C, C., ML, S., M, T. F., A, L., E, C., . . . MP, S. (2022). Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies. Multiple sclerosis (Houndmills, Basingstoke, England), 28(13), 2106. https://doi.org/10.1177/13524585221102918

Chicago Style (17th ed.) Citation

I, Schiavetti, et al. "Breakthrough SARS-CoV-2 Infections in MS Patients on Disease-modifying Therapies." Multiple Sclerosis (Houndmills, Basingstoke, England) 28, no. 13 (2022): 2106. https://doi.org/10.1177/13524585221102918.

MLA (9th ed.) Citation

I, Schiavetti, et al. "Breakthrough SARS-CoV-2 Infections in MS Patients on Disease-modifying Therapies." Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 28, no. 13, 2022, p. 2106, https://doi.org/10.1177/13524585221102918.